Workflow
Lilly(LLY) - 2025 Q3 - Earnings Call Transcript

Eli Lilly (NYSE:LLY) Q3 2025 Earnings Call October 30, 2025 10:00 AM ET Company ParticipantsAkash Tewari - Global Head of Biopharmaceutical ResearchLucas Montarce - CFOChris Schott - Managing DirectorGeoff Meacham - Managing DirectorTerence Flynn - Managing Director of Equity ResearchDan Skovronsky - CSO and President of Lilly ImmunologyMohit Bansal - Managing Director and Co-head of Therapeutics ResearchMike Czapar - SVP of Investor RelationsPatrik Jonsson - President of Lilly InternationalDave Ricks - Cha ...